CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
December 2019—Beckman Coulter announced that its DxA 5000 total laboratory automation solution has received FDA 510(k) clearance and is available for sale in the United States.
The DxA 5000 helps eliminate preanalytical errors by automatically detecting patient tube parameters such as sample identification, tube type, orders pending, and tube weight in the first three seconds. The system screens each sample at multiple points to help reduce the risk of errors and alerts laboratorians if action is needed. It reduces the number of manual steps in sample processing from 32 to four. By understanding the tests requested, sample volume available, and real-time analyzer capacity and status, the DxA 5000 continuously calculates the most expeditious route for stat and routine patient samples.